AbbVie Inc. (NEO:ABBV)
Canada
· Delayed Price · Currency is CAD 26.80
-1.25 (-4.46%)
May 6, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Immunology | 26.68B |
Log In |
Log In |
Log In |
Log In |
| Immunology Growth | 2.09% |
Log In |
Log In |
Log In |
Log In |
| Oncology | 6.56B |
Log In |
Log In |
Log In |
Log In |
| Oncology Growth | 10.82% |
Log In |
Log In |
Log In |
Log In |
| Other Key Products | 3.65B |
Log In |
Log In |
Log In |
Log In |
| Other Key Products Growth | -4.15% |
Log In |
Log In |
Log In |
Log In |
| All Other | 3.03B |
Log In |
Log In |
Log In |
Log In |
| All Other Growth | -0.10% |
Log In |
Log In |
Log In |
Log In |
| Neuroscience | 9.00B |
Log In |
Log In |
Log In |
Log In |
| Neuroscience Growth | 16.61% |
Log In |
Log In |
Log In |
Log In |
| Women's Health | - |
Log In |
Log In |
Log In |
Log In |
| Women's Health Growth | - |
Log In |
Log In |
Log In |
Log In |
| Aesthetics | 5.18B |
Log In |
Log In |
Log In |
Log In |
| Aesthetics Growth | -2.23% |
Log In |
Log In |
Log In |
Log In |
| Eye Care | 2.24B |
Log In |
Log In |
Log In |
Log In |
| Eye Care Growth | -7.16% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| United States | 43.03B |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 2.74% |
Log In |
Log In |
Log In |
Log In |
| International | 13.31B |
Log In |
Log In |
Log In |
Log In |
| International Growth | 7.00% |
Log In |
Log In |
Log In |
Log In |